Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tong-Mai Yang-Xin pill for delaying myocardial remodeling after PCI in acute anterior myocardial infarction
ChiCTR1900023023Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Dec 2018
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis and myocardial infarction (MI) comparing Conventional medicine + placebo with Conventional medicine + Tong-Mai Yang-Xin pill (2 arms). Primary endpoint: left ventricular end-diastolic volume index at 3 months. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
Tongmai Yangxin Pills
03
Conditions
coronary arteriosclerosismyocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR1900023023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023023.